1FujimoriA,Naito H,Miyazaki T,et al. Time course of changes in pertoneal tissue and mediators thereof. Perit Dial Int, 1998.18(Suppl 2) :71.
2Descamps LB, Herbelin A, Nguyen AT ,et al. Balance between IL-1β,TNFa,and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of Tcells, B cells ,and monocyes. J Immunol, 1995,154(8) : 822.
3Kozil MM,Ksiazek A. Cytokine soluble receptors ,sIL-2R, sIL-6R and sTNF-R concentrations in the serum of patients on(CAPD)treatment. Perit Dial Int, 1998,18(suppl 2) :36.
4Yung S. Coles GA. Davies M. IL-1β, a major stimulator of hyaluronare synthesis in vitro of human eritoneal mesothelial cells : relevance to peritonitis in CAPD. Kidney Int. 1996, 50(12)~1337.
5Breborwicz A ,Korybalska K,Grzybowski A.et al. Synthesis of hyaluronic acid by human peritoneal mesotheial cells:effect of cytokines and dialysate . Perk Dial Int, 1996,16(suppl 2) : 374.
6Schambye HT. Effect of different buffers on the biocompatibility of CAPD solutions. Petit Dial Int ,1996,16(Suppl 1) :130.
7Schein M, Wittmann DH, Holzheimer R, et al. Hypothesis : Comartmentalization of cytokines in intraabdominal infection.Surgery, 1996,119(6) : 694.
8McGregor Sj. Topley N, Jorres A.et al. Longitudinal evaluation of peritoneal macrophage function and activation during CAPD: matutity, cytokine synthesis and arachidonic acid metabolism.Kidney Int. 1996,49(5) .. 525.
9Cappa F, Verrina E, Barbano G ,et al . TGF-1β, IL-4, AND IFNγ are detectable in uninfected peritoneal effluents (PE)of childrenon CAPD. Perit Dial Int. 1998,18(suppl 2) :36.
10Choi KH,Lee IH,Shin Sk.et al. interleukin-1β、6 ,and interferon-γ production in CAPD. perit Dial int,1998,18(Suppl 2):36.
